Selective Inhibitors of Histone Methyltransferase DOT1L: Design, Synthesis, and Crystallographic Studies
- 21 September 2011
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 133 (42), 16746-16749
- https://doi.org/10.1021/ja206312b
Abstract
Histone H3-lysine79 (H3K79) methyltransferase DOT1L plays critical roles in normal cell differentiation as well as initiation of acute leukemia. We used structure- and mechanism-based design to discover several potent inhibitors of DOT1L with IC50 values as low as 38 nM. These inhibitors exhibit only weak or no activities against four other representative histone lysine and arginine methyltransferases, G9a, SUV39H1, PRMT1 and CARM1. The X-ray crystal structure of a DOT1L–inhibitor complex reveals that the N6-methyl group of the inhibitor, located favorably in a predominantly hydrophobic cavity of DOT1L, provides the observed high selectivity. Structural analysis shows that it will disrupt at least one H-bond and/or have steric repulsion for other histone methyltransferases. These compounds represent novel chemical probes for biological function studies of DOT1L in health and disease.Keywords
This publication has 21 references indexed in Scilit:
- Chemogenetic Analysis of Human Protein MethyltransferasesChemical Biology & Drug Design, 2011
- Epigenetic control of T-helper-cell differentiationNature Reviews Immunology, 2009
- H3K79 Methylation Profiles Define Murine and Human MLL-AF4 LeukemiasCancer Cell, 2008
- Chemical probes for histone-modifying enzymesNature Chemical Biology, 2008
- In Situ Generation of a Bisubstrate Analogue for Protein Arginine Methyltransferase 1Journal of the American Chemical Society, 2008
- Epigenetic regulation in psychiatric disordersNature Reviews Neuroscience, 2007
- Chromatin Modifications and Their FunctionCell, 2007
- The Epigenomics of CancerCell, 2007
- Analysis of prognostic factors of acute lymphoblastic leukemia in infants: report on CCG 1953 from the Children's Oncology GroupBlood, 2006
- hDOT1L Links Histone Methylation to LeukemogenesisCell, 2005